ReviewCell2023
Pancreatic cancer: Advances and challenges.
- Journal
- Cell
- Published
- 1 April 2023
- Citations
- 1,004
- Type
- Review
- License
- cc by-nc-nd
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 14
- Administrative Supplement P30 Cancer Center Support Grant (CCSG): Phase 1 Study of Olaparib in Combination with Durvalu… P30CA046592↗
- Administrative Core P50CA221707↗
- Disrupting macrophage metabolism to reduce immunosuppression and enhance therapy in pancreatic cancer R00CA241357↗
- Wnt/?-catenin Signaling in Pancreatic Oncogenesis R01CA220236↗
- Targeting metabolic stress to induce pancreatic tumor cell death R01CA244931↗
- Stromal metabolism promotes therapeutic resistance in pancreatic cancer R01CA248160↗
- Targeting the fibroblast-immune cell crosstalk to relieve immune suppression in the pancreatic cancer microenvironment R01CA260752↗
- Establishment and regulation of the immune suppressive microenvironment in pancreatic cancer R01CA264843↗
- Dissecting the role of Notch signaling in the pancreatic cancer microenvironment. R01CA271510↗
- Intratumoral Metabolic Crosstalk Promotes Therapeutic Resistance in Pancreatic Cancer R37CA237421↗
- Clinical Validation Center for Early Detection of Pancreatic Cancer U01CA200468↗
- Fibroblast orchestration of the immune response in pancreatic cancer U01CA274154↗
- PASSCODE (Pancreatic Adenocarcinoma Stromal Reprograming ConSortium COordination, Data Management and Education) U24CA274274↗
- TBEL Project 3 U54CA274371↗